Home
>
National Drug Code (NDC)
>
Fenofibrate
Fenofibrate - 0115-0522-02 - (FENOFIBRATE)
Drug Information of Fenofibrate
| Product NDC: | 0115-0522 |
| Proprietary Name: | Fenofibrate |
| Non Proprietary Name: | FENOFIBRATE |
| Active Ingredient(s): | 134 mg/1 & nbsp; FENOFIBRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fenofibrate
| Product NDC: | 0115-0522 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075868 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100201 |
Package Information of Fenofibrate
| Package NDC: | 0115-0522-02 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (0115-0522-02) |
NDC Information of Fenofibrate
| NDC Code | 0115-0522-02 |
| Proprietary Name | Fenofibrate |
| Package Description | 500 CAPSULE in 1 BOTTLE (0115-0522-02) |
| Product NDC | 0115-0522 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FENOFIBRATE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100201 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | FENOFIBRATE |
| Strength Number | 134 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
